Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-24-002812

Options or other derivatives

  • Head of Pharm Ops and Tech acquired 856 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Murphy Nicole · Head of Pharm Ops and Tech

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-29 Grant or award : show line 1 in the form Performance Stock Unit +856 856 D
Loading xslF345X05/form4.xml…